Atai Beckley (ATAI) said Tuesday its common stock has been added to the Nasdaq Biotechnology Index, effective prior to market open on Dec. 22.
The index tracks the performance of a set of securities listed on Nasdaq that are classified as either biotechnology or pharmaceutical and is calculated under a modified capitalization-weighted methodology, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments